Meet our Clinical Advisory Board

In conjunction with launching clinical trials in 2014, we formed our Clinical Advisory Board. Its members are globally recognized medical specialists with substantial experience and expertise in clinical trial protocol design.

Dean and Professor of Medicine  Chinese University of Hong Kong, China

Board Member  Hong Kong Hospital Authority

Dr. Chan is an expert in digestive diseases. He has led many clinical trials, including several landmark studies of Celebrex, one of the most widely used NSAIDs.

He is Dean of Medicine at the Chinese University of Hong Kong and one of the world’s most recognized and respected gastroenterologists.


MD  Chinese University of Hong Kong
Residency at the Prince of Wales Hospital, Hong Kong
DSc  Chinese University of Hong Kong
Postdoctoral studies at the University of Calgary, Canada

Dr. Chan has received numerous awards, including The David Y. Graham Lecturer Award and the Leadership Award from the American College of Gastroenterology. He has published extensively in leading medical journals, including The New England Journal of Medicine and The Lancet.

“The need for a new generation of pain and inflammation drugs has never been more urgent.”

Professor of Medicine and Chief of Gastroenterology  University Hospital, Institute of Health Sciences, Zaragoza, Spain
Vice-Dean for Research Affairs  School of Medicine, University of Zaragoza, Spain
Scientific Director  Aragón Health Research Institute, IIS Aragón, Spain

As a medical doctor, and scientist, Dr. Lanas’s research has focused on the adverse effects of NSAIDs on the gastrointestinal tract. He has led multiple pioneering medical research studies and clinical trials, drawing attention to the significant ulceration and bleeding that NSAIDs cause in the small intestine, and the fact that such damage typically goes undiagnosed.

Early in his career, he was visiting professor of gastroenterology at the University of Alabama, USA. He is former President of the Gastroenterology Association in Spain.


MD  University of Zaragoza, Spain
Residency at Lozano Blesa University Hospital, Spain
DSc  University of Zaragoza, Spain

Honorary Professor
Chinese University of Hong Kong

International Fellow
American College of Gastroenterology
American Gastroenterological Association

Dr Lanas has published more than 350 articles in leading medical journals, including The New England Journal of Medicine, Nature and The Lancet.

“We now know that NSAIDs can also damage the small intestine, a fact only confirmed with the recent availability of capsule endoscopy.”

Chief, Division of Gastroenterology & Hepatology  University of Virginia Health System, USA

As a medical doctor and scientist, Dr. Scheiman focuses on acid-related disorders such as peptic ulcer disease and gastroesophageal reflux disease. He also studies the early diagnosis of gastrointestinal malignancies, particularly pancreatic cancer.

He has published on the cost-effective application of several new diagnostic approaches and therapies.


MD  University of Michigan, USA
Residency and Fellowship at the University of Michigan Affiliated Hospitals, USA

Dr. Scheiman’s research on preventing gastrointestinal damage by NSAIDs has defined today’s clinical approach to this drug class. He is the author of more than 250 original scientific publications and book chapters.

“NSAIDs are effective medicines—we need to develop strategies to reduce gastrointestinal and other adverse events associated with their use.”


Division Chief, Rheumatology and Director, Arthritis Program  Southlake Regional Health Centre, Ontario, Canada

Dr. Thorne specializes in internal medicine and rheumatology, involving the treatment inflammation and pain in joints, muscles, and ligaments.

He is former President of the Canadian Rheumatology Association. He has been a director of the Arthritis Society in Canada, treasurer of the Panamerican League of Associations for Rheumatology, and an executive member of the Canadian Rheumatology Research Consortium.


MD  Faculty of Medicine, University of Toronto, Canada

American College of Physicians
American College of Rheumatology
Royal College of Physicians and Surgeons, Canada
Royal College of Physicians in Internal Medicine and Rheumatology, Canada

Dr. Thorne is the recipient of Distinguished Rheumatologist Award from the American College of Rheumatology.

“As a physician and scientist, I am constantly aware of the difficult tradeoffs inherent in today’s pain medications.”


This is an external link. Click “OK” to continue.